Sign Up Today and Learn More About BioConsortia Stock
Invest in or calculate the value of your shares in BioConsortia or other pre-IPO companies through EquityZen's platform.
BioConsortia Stock (BIOO)
BioConsortia is developing highly effective microbial consortia for increasing agricultural yields.
About BioConsortia Stock
Founded
2014
Headquarters
Davis, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
BioConsortia is developing highly effective microbial consortia for increasing agricultural yields. Soil and plant associated microbes interact with and supplement the functions encoded by the crop genome. Opportunities abound to exploit these plant-microbe interactions but overwhelming complexity and the huge amount of genetic diversity has hindered the realization of these by conventional R&D methods. BioConsortia has developed a revolutionary Advanced Microbial Selection (AMS) process for crop trait enhancement that uses iterative rounds of plant phenotyping and selection to co-select for beneficial changes in the microbiome. Isolates are obtained from the microbiome of plants expressing the desired traits and are developed as consortia for application as commercial seed treatment, drench or granule products. We have a pipeline of products for increased fertilizer utilization, growth improvement and other beneficial crop traits, such as abiotic tolerance and enhanced metabolite expression.
BioConsortia Press Mentions
Stay in the know about the latest news on BioConsortia
BioConsortia Receives US-EPA Registration for Amara Biofungicide
businesswire • Oct 07, 2024
BioConsortia unveils latest bionematicide results from Brazil
businesswire • Aug 05, 2024
BioConsortia raises $15m in funding for advanced microbial solutions
foodbev • May 05, 2024
BioConsortia Expands Nitrogen-fixing Microbial Products for Row Crops to New Territories and New Product Concepts ...
biospace • May 05, 2024
Methods and compositions for refactoring nitrogen fixation clusters
patents • Apr 14, 2024
BioConsortia Management
Leadership team at BioConsortia
Board of Directors
Andrew Chung
Senior Vice President, Operations & Administration
Christina Huben
Join now and verify your accreditation status to gain access to:
- BioConsortia current valuation
- BioConsortia stock price
- Available deals in BioConsortia and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in BioConsortia stock?
Accredited investors can buy pre-IPO stock in companies like BioConsortia through EquityZen funds. These investments are made available by existing BioConsortia shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell BioConsortia stock?
Shareholders can sell their BioConsortia stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."